| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alanine:sodium symporter activity | 2.22e-05 | 4 | 39 | 2 | GO:0015655 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.03e-04 | 8 | 39 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.66e-04 | 10 | 39 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 4.38e-04 | 16 | 39 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.29e-04 | 81 | 39 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 9.16e-04 | 23 | 39 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.08e-03 | 25 | 39 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.46e-03 | 29 | 39 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.61e-03 | 119 | 39 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | complement binding | 1.78e-03 | 32 | 39 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.12e-03 | 35 | 39 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.59e-03 | 296 | 39 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.75e-03 | 301 | 39 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.90e-03 | 41 | 39 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | symporter activity | 3.11e-03 | 150 | 39 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.50e-03 | 171 | 39 | 3 | GO:0015081 | |
| GeneOntologyCellularComponent | symbiont cell surface | 9.92e-05 | 8 | 40 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.27e-04 | 9 | 40 | 2 | GO:0044217 | |
| Domain | RPAP3-like_C | 1.34e-05 | 3 | 40 | 2 | IPR025986 | |
| Domain | RPAP3_C | 1.34e-05 | 3 | 40 | 2 | PF13877 | |
| Domain | Anaphylatoxin_comp_syst | 4.45e-05 | 5 | 40 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.45e-05 | 5 | 40 | 2 | IPR001840 | |
| Domain | ANATO | 9.33e-05 | 7 | 40 | 2 | SM00104 | |
| Domain | ANATO | 9.33e-05 | 7 | 40 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 9.33e-05 | 7 | 40 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 9.33e-05 | 7 | 40 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 9.33e-05 | 7 | 40 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 1.24e-04 | 8 | 40 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.24e-04 | 8 | 40 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 1.24e-04 | 8 | 40 | 2 | IPR019742 | |
| Domain | A2M_N | 1.99e-04 | 10 | 40 | 2 | PF01835 | |
| Domain | A2M_N | 1.99e-04 | 10 | 40 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.99e-04 | 10 | 40 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.99e-04 | 10 | 40 | 2 | PS00477 | |
| Domain | A2M | 1.99e-04 | 10 | 40 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.99e-04 | 10 | 40 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.99e-04 | 10 | 40 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.99e-04 | 10 | 40 | 2 | PF07703 | |
| Domain | A2M_recep | 1.99e-04 | 10 | 40 | 2 | PF07677 | |
| Domain | A2M_comp | 1.99e-04 | 10 | 40 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.99e-04 | 10 | 40 | 2 | IPR001599 | |
| Domain | Ras_G-nucl-exch_fac_CS | 4.00e-04 | 14 | 40 | 2 | IPR019804 | |
| Domain | C345C | 5.96e-04 | 17 | 40 | 2 | SM00643 | |
| Domain | Aa_trans | 5.96e-04 | 17 | 40 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 5.96e-04 | 17 | 40 | 2 | IPR013057 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.70e-04 | 18 | 40 | 2 | IPR008930 | |
| Domain | NTR | 7.47e-04 | 19 | 40 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 7.47e-04 | 19 | 40 | 2 | IPR018933 | |
| Domain | RasGEF_N | 9.15e-04 | 21 | 40 | 2 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.01e-03 | 22 | 40 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 1.01e-03 | 22 | 40 | 2 | PS50212 | |
| Domain | NTR | 1.10e-03 | 23 | 40 | 2 | PS50189 | |
| Domain | Netrin_domain | 1.10e-03 | 23 | 40 | 2 | IPR001134 | |
| Domain | RASGEF | 1.41e-03 | 26 | 40 | 2 | PS00720 | |
| Domain | TIMP-like_OB-fold | 1.41e-03 | 26 | 40 | 2 | IPR008993 | |
| Domain | RASGEF_CAT | 1.75e-03 | 29 | 40 | 2 | PS50009 | |
| Domain | RasGEF | 1.87e-03 | 30 | 40 | 2 | PF00617 | |
| Domain | - | 1.87e-03 | 30 | 40 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 1.87e-03 | 30 | 40 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 1.87e-03 | 30 | 40 | 2 | IPR001895 | |
| Domain | RasGEF | 1.87e-03 | 30 | 40 | 2 | SM00147 | |
| Domain | TPR_8 | 5.75e-03 | 53 | 40 | 2 | PF13181 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 4.42e-05 | 7 | 21 | 2 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 5.89e-05 | 8 | 21 | 2 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 5.89e-05 | 8 | 21 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.15e-04 | 11 | 21 | 2 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.15e-04 | 11 | 21 | 2 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.38e-04 | 12 | 21 | 2 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.63e-04 | 13 | 21 | 2 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.84e-04 | 17 | 21 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.84e-04 | 17 | 21 | 2 | MM1369 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.78e-04 | 238 | 21 | 4 | MM15076 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.95e-04 | 20 | 21 | 2 | M917 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.49e-04 | 249 | 21 | 4 | M5988 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 4.80e-04 | 22 | 21 | 2 | M39502 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.26e-04 | 108 | 21 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.40e-04 | 109 | 21 | 3 | MM15074 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.02e-03 | 32 | 21 | 2 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.09e-03 | 33 | 21 | 2 | M188 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 1.76e-03 | 42 | 21 | 2 | MM15945 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.76e-03 | 681 | 21 | 5 | MM14985 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.89e-03 | 54 | 21 | 2 | MM14655 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.44e-03 | 59 | 21 | 2 | MM15838 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.87e-03 | 736 | 21 | 5 | M27287 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 4.67e-03 | 69 | 21 | 2 | M16894 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.36e-06 | 2 | 41 | 2 | 16565498 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15998580 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.36e-06 | 2 | 41 | 2 | 25339671 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17728371 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.36e-06 | 2 | 41 | 2 | 7373044 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.36e-06 | 2 | 41 | 2 | 3696167 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6149580 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6149581 | ||
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.36e-06 | 2 | 41 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.36e-06 | 2 | 41 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.36e-06 | 2 | 41 | 2 | 19933335 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12115608 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 3542363 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2387317 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 8132550 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.36e-06 | 2 | 41 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.36e-06 | 2 | 41 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.36e-06 | 2 | 41 | 2 | 15787745 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12207352 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2395880 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26814708 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6192448 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6167582 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 16908004 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30026462 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 1.36e-06 | 2 | 41 | 2 | 1438267 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7365238 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.36e-06 | 2 | 41 | 2 | 27758680 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19150565 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7391573 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17506029 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22387014 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17971360 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.36e-06 | 2 | 41 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.36e-06 | 2 | 41 | 2 | 20506482 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23715124 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 3464002 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.36e-06 | 2 | 41 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.36e-06 | 2 | 41 | 2 | 17971229 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12480675 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6881182 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.36e-06 | 2 | 41 | 2 | 23749435 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23918728 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 1.36e-06 | 2 | 41 | 2 | 3944109 | |
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.36e-06 | 2 | 41 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.36e-06 | 2 | 41 | 2 | 3037333 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11726230 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 4216347 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.36e-06 | 2 | 41 | 2 | 17921792 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21880985 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.36e-06 | 2 | 41 | 2 | 1699796 | |
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.36e-06 | 2 | 41 | 2 | 6978711 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.36e-06 | 2 | 41 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.36e-06 | 2 | 41 | 2 | 2997024 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 35898513 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33353966 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 3008092 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.36e-06 | 2 | 41 | 2 | 3624865 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 28873507 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.36e-06 | 2 | 41 | 2 | 8428773 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21857912 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 1.36e-06 | 2 | 41 | 2 | 2900855 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24638111 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.36e-06 | 2 | 41 | 2 | 4514997 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 276882 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.36e-06 | 2 | 41 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.36e-06 | 2 | 41 | 2 | 5919331 | |
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 1.36e-06 | 2 | 41 | 2 | 6832377 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.36e-06 | 2 | 41 | 2 | 3167981 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 3794341 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 1.36e-06 | 2 | 41 | 2 | 17257223 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2272665 | ||
| Pubmed | Multiple C4/Slp genes distinguished by expression after transfection. | 1.36e-06 | 2 | 41 | 2 | 3023818 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7545960 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30041577 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2572548 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22785613 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.36e-06 | 2 | 41 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.36e-06 | 2 | 41 | 2 | 34358307 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32691186 | ||
| Pubmed | Genetic deficiency in complement component 4b does not alter radiation-induced lung disease in mice. | 1.36e-06 | 2 | 41 | 2 | 23259761 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.36e-06 | 2 | 41 | 2 | 18360261 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.36e-06 | 2 | 41 | 2 | 18091514 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 29080553 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11168010 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 1.36e-06 | 2 | 41 | 2 | 8390682 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.36e-06 | 2 | 41 | 2 | 26814963 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6589636 | ||
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 1.36e-06 | 2 | 41 | 2 | 3902619 | |
| Pubmed | Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17. | 4.06e-06 | 3 | 41 | 2 | 681746 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.50e-04 | 423 | 41 | 4 | chr12q13 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.23e-05 | 37 | 27 | 3 | 454 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.68e-05 | 9 | 27 | 2 | 1234 | |
| GeneFamily | Complement system|Sushi domain containing | 1.31e-03 | 36 | 27 | 2 | 492 | |
| GeneFamily | Solute carriers | 2.64e-03 | 395 | 27 | 4 | 752 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.27e-02 | 115 | 27 | 2 | 769 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-07 | 164 | 41 | 5 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 159 | 41 | 4 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 159 | 41 | 4 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 166 | 41 | 4 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 166 | 41 | 4 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 172 | 41 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 172 | 41 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | 4bb54043f944a979db91bde9a86dd66f498c7658 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Fos_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.50e-05 | 80 | 41 | 3 | b661644806e225f215047e78ae46d7cee6efde4f | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 5.50e-05 | 80 | 41 | 3 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| Drug | 2-aminothiophenol | 9.48e-06 | 3 | 41 | 2 | ctd:C005464 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.64e-05 | 56 | 39 | 3 | EFO_0022250 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 5.74e-05 | 315 | 39 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 6.59e-05 | 59 | 39 | 3 | EFO_0022289 | |
| Disease | total lipids in small VLDL | 9.64e-05 | 67 | 39 | 3 | EFO_0022148 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.96e-04 | 85 | 39 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.02e-04 | 86 | 39 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.29e-04 | 17 | 39 | 2 | EFO_0022232 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.25e-04 | 101 | 39 | 3 | EFO_0004530, EFO_0007878 | |
| Disease | lipoprotein measurement | 3.65e-04 | 105 | 39 | 3 | EFO_0004732 | |
| Disease | inflammatory biomarker measurement | 5.42e-04 | 26 | 39 | 2 | EFO_0004872 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 5.85e-04 | 27 | 39 | 2 | EFO_0022238 | |
| Disease | non-alcoholic fatty liver disease severity measurement | 6.30e-04 | 28 | 39 | 2 | EFO_0008421 | |
| Disease | choline measurement | 6.80e-04 | 130 | 39 | 3 | EFO_0010116 | |
| Disease | blood viscosity | 7.73e-04 | 31 | 39 | 2 | EFO_0004301 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 7.81e-04 | 315 | 39 | 4 | EFO_0004574, EFO_0004612 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 8.37e-04 | 321 | 39 | 4 | EFO_0004612, EFO_0004639 | |
| Disease | phospholipid measurement | 8.43e-04 | 140 | 39 | 3 | EFO_0004639 | |
| Disease | Complement deficiency disease | 8.76e-04 | 33 | 39 | 2 | C0272242 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 9.28e-04 | 330 | 39 | 4 | EFO_0004529, EFO_0004612 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 9.30e-04 | 34 | 39 | 2 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | free cholesterol in small HDL measurement | 9.85e-04 | 35 | 39 | 2 | EFO_0022270 | |
| Disease | diabetic nephropathy | 1.03e-03 | 150 | 39 | 3 | EFO_0000401 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.10e-03 | 37 | 39 | 2 | EFO_0022281 | |
| Disease | Graves' disease (is_implicated_in) | 1.22e-03 | 39 | 39 | 2 | DOID:12361 (is_implicated_in) | |
| Disease | aspirin use measurement | 1.22e-03 | 39 | 39 | 2 | EFO_0007013 | |
| Disease | cholesterol in very small VLDL measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0022231 | |
| Disease | free cholesterol in medium LDL measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0022268 | |
| Disease | factor VIII measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0004630 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RILKFLKLFITEFPK | 171 | P54619 | |
| FAIKKYVAFLKLFLE | 121 | P16442 | |
| FEVKKYVLPNFEVKI | 231 | P0C0L5 | |
| FYKVIPKSKFVLVKF | 46 | P30040 | |
| VKKKFTFIDYLLIIL | 81 | Q5VYY1 | |
| VKFLLKLPYIDSKRL | 631 | Q8N608 | |
| VNKVAYCPLVLKFKF | 1086 | Q9UKP5 | |
| FLIPEVQKYFVKEKV | 701 | Q7Z4T9 | |
| LFKKEILETKAPYRI | 111 | Q96LI6 | |
| VIKYKDYFPVILKRA | 171 | Q9UBF1 | |
| FKKYLARKILDFKLP | 26 | P59045 | |
| LIPLKRKRKYFKVFE | 1916 | Q8IVV2 | |
| VYKILEPEALKFFKI | 1801 | Q9NYQ8 | |
| LVFVLLLVKRFIPKY | 191 | A6NFY4 | |
| FTVLEKFRYLPKAIK | 281 | Q9Y4W2 | |
| KDEVYQKIILKFPLL | 86 | Q8IV76 | |
| KLILLEKKVLFYISP | 196 | Q8NBF6 | |
| LFILPFVSVAKEKKY | 141 | O75417 | |
| FEVKKYVLPNFEVKI | 231 | P0C0L4 | |
| YIIIVPLKKSRGKFI | 1141 | P23468 | |
| FKPYIIFVKPAIQEK | 496 | Q13368 | |
| FKISKIYKPLLFMDL | 641 | Q969X6 | |
| YVKKLKQDFILVPLF | 336 | B5MCY1 | |
| FKPYISKLFDRKILK | 271 | P28749 | |
| VGLAVFLIYKFKRKI | 1136 | Q9UPU3 | |
| LKDILKLFPFLKCPY | 326 | Q8N6K7 | |
| YPILEKELKEFQKIL | 186 | Q92565 | |
| PYKVDPFVIIIKFLL | 636 | Q75T13 | |
| FILPAVFYLKLVKKE | 491 | Q969I6 | |
| DLVIKVYLKGVHPKF | 111 | Q9UHQ9 | |
| IFKGIFAIIKPFLKE | 231 | Q9BTX7 | |
| VLISALIIYFKPEYK | 231 | Q8IWU4 | |
| FYIEKEKPLLIFEIL | 601 | Q9H6T3 | |
| FILPSAFYIKLVKKE | 451 | Q96QD8 | |
| KIVIPFFSLLIKDIY | 361 | Q8N431 | |
| KTFKIPIEHLDFKYI | 16 | Q07617 | |
| IKKTLEIYVPIKQFF | 2161 | Q9H5I5 | |
| VLFLLLYVIYKKPEV | 596 | P55017 | |
| FLDLKEFLPKEYIKQ | 261 | Q9Y4G6 | |
| KLEPFQKELYKEVLL | 186 | Q8TF39 | |
| EEYKLGKTKIFIRFP | 676 | Q8N1T3 |